RRP ISA Survey Results
    Professionals & Researchers

    (Important Disclaimer)

    Professionals & Researchers

    News About HPV

    HPV causing more oral cancer in men

    ATLANTA - The sexually transmitted virus that causes cervical cancer in women is poised to become one of the leading causes of oral cancer in men, according to a new study. The only available vaccine against HPV, made by Merck & Co. Inc., is currently given only to girls and young women. But Merck plans this year to ask government permission to offer the shot to boys.
    by MIKE STOBBE, AP Medical Writer

    Head and Neck Cancer HPV Involvement

    HPV Linked to Head and Neck Cancers; Possible New Role for HPV Vaccine
    by ASCO through HONI Online

    HPV Today (fall 2007 newsletter)

    by Dr. Keerti Shah, et al

    Symposium on New HPV Prophylactic Vaccines

    This is a link to a symposium on HPV prophylactic vaccines.
    by Dr. Tom Broker, et al


    These articles about the AAV2 virus and HPV and associated cancers are quite interesting. There is a need for more research into this and other HPV treatments. One of the tasks of the International RRP ISA Center is to investigate and support further research into potential treatments for RRP patients.
    by National Cancer Institute

    Case report of a laryngeal squamous cell carcinoma treated with artesunate (artemisinin analogue)

    Artenusate appears to have greatly helped one patient. First known report on the use of artemisinin  for cancer in humans. It has been widely used for malaria.
    by Narendra Singh, et al (U of W)